Anivive, a software-driven pet health company, announces the expansion of its Long Beach lab to accommodate increased demand for its specialty pathology services through Vidium, a leader in veterinary ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

TD Cowen analyst Daniel Brennan maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $140.00. The ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

We recently published a list of Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus. In this article, we are going to take ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Companies spend millions developing logos to represent a brand. Some of them have hidden meanings steeped in the history and ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

Citigroup cut their target price on shares of Illumina from $130.00 to $90.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. TD Cowen downgraded shares of ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...